Author:
Fujikura Emi,Akiu Maho,Miyauchi Kenichiro,Yoshida Mai,Aoki Satoshi,Yamamoto Tae,Narumi Kaori,Yanagisawa Noriko,Nakamichi Takashi,Miyazaki Mariko,Sato Hiroshi,Ito Sadayoshi
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Urology,Nephrology
Reference26 articles.
1. Stoller RG, Hande KR, Jacobs SA, Rosenberg SA, Chabner BA. Use of plasma pharmacokinetics to predict and prevent methotrexate toxicity. New England J Med. 1977;297:630–4.
2. Isacoff WH, Eilber F, Tabbarah H, et al. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue. Cancer Treat Rep. 1978;62:1295–304.
3. Pfizer Inc. Methotrexate® fluid for intravenous injection 200 mg pharmaceutical interview form. In Japanese.
www.info.pmda.go.jp/go/interview/2/671450_4222400A1036_2_1F
. Accessed 05 Sept 2017.
4. Kono K, Matsumi M, Tokioka H, Nagano O, Iwado S, Hirakawa M. A case of methotrexate-poisoning associated acute renal failure successfully treated with blood purification. J Japan Soc Intensive Care Med. 1996;2:107–11.
5. Bouffet E, Frappaz D, Laville M, Finaz J, Pinkerton CR, Philip T, Brunat-Mentigny M. Charcoal hemoperfusion and methotrexate toxicity. Lancet. 1986;1(8496):1497.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献